Invesco S&P 500 Equal Weight Health Care ETFInvesco S&P 500 Equal Weight Health Care ETFInvesco S&P 500 Equal Weight Health Care ETF

Invesco S&P 500 Equal Weight Health Care ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪741.49 M‬USD
Fund flows (1Y)
‪−173.08 M‬USD
Dividend yield (indicated)
0.64%
Discount/Premium to NAV
−0.08%
Shares outstanding
‪25.88 M‬
Expense ratio
0.40%

About Invesco S&P 500 Equal Weight Health Care ETF


Brand
Invesco
Home page
Inception date
Nov 1, 2006
Structure
Open-Ended Fund
Index tracked
S&P 500 Equal Weighted / Health Care -SEC
Replication method
Physical
Management style
Passive
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
Invesco Capital Management LLC
Distributor
Invesco Distributors, Inc.
RSPH holds a portfolio of health care companies from the S&P 500. Instead of weighting its holdings by market cap, RSPH uses an equal-weighting scheme. The result is a portfolio that does not deviate much from the broad US health care market but is still far less concentrated than the industry with a skew toward midcaps. This causes profound industry tilts, though it doesn't necessarily add more risk. With less concentration in pharma, RSPH provides more balanced exposure to other industries within the health care sector such as equipment & supplies, healthcare providers, and drug retailers. The index is rebalanced on a quarterly basis. Prior to June 07, 2023, the fund traded under the ticker, RYH.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
Equal
Geography
U.S.
Weighting scheme
Equal
Selection criteria
Committee

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of June 6, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Health Services
Stocks99.92%
Health Technology68.98%
Health Services21.87%
Distribution Services7.62%
Commercial Services1.44%
Bonds, Cash & Other0.08%
Mutual fund0.08%
Stock breakdown by region
96%3%
North America96.52%
Europe3.48%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


RSPH invests in stocks. The fund's major sectors are Health Technology, with 68.98% stocks, and Health Services, with 21.87% of the basket. The assets are mostly located in the North America region.
RSPH top holdings are IDEXX Laboratories, Inc. and Insulet Corporation, occupying 2.17% and 2.14% of the portfolio correspondingly.
RSPH last dividends amounted to 0.06 USD. The quarter before, the issuer paid 0.06 USD in dividends, which shows a 3.36% decrease.
RSPH assets under management is ‪741.49 M‬ USD. It's fallen 1.48% over the last month.
RSPH fund flows account for ‪−173.08 M‬ USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, RSPH pays dividends to its holders with the dividend yield of 0.64%. The last dividend (Mar 28, 2025) amounted to 0.06 USD. The dividends are paid quarterly.
RSPH shares are issued by Invesco Ltd. under the brand Invesco. The ETF was launched on Nov 1, 2006, and its management style is Passive.
RSPH expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
RSPH follows the S&P 500 Equal Weighted / Health Care -SEC. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
RSPH invests in stocks.
RSPH price has risen by 2.81% over the last month, and its yearly performance shows a −5.37% decrease. See more dynamics on RSPH price chart.
NAV returns, another gauge of an ETF dynamics, showed a −5.56% decrease in three-month performance and has decreased by −4.86% in a year.
RSPH trades at a premium (0.08%) meaning the ETF is trading at a higher price than the calculated NAV.